超声内镜引导与ERCP引导胆道引流作为恶性远端胆道梗阻一线方案:随机对照试验的系统评价与Meta分析
该Meta分析纳入5项RCT共519例恶性远端胆道梗阻患者,比较EUS-BD与ERCP引导胆道引流的结局。EUS-BD与ERCP总体技术成功和临床成功无显著差异,但EUS-BD支架功能障碍风险更低且操作相关胰腺炎为零,操作时间更短。
要点
- EUS-BD与ERCP总体技术成功和临床成功无显著差异。
- EUS-BD支架功能障碍风险显著低于ERCP(RR=0.48)。
- ERCP组操作相关胰腺炎汇总发生率7.20%,EUS-BD组为零。
核心结论
- 在恶性远端胆道梗阻中,EUS-BD是ERCP高效且安全的替代方案。
- EUS-BD几乎无操作相关胰腺炎风险、操作时间更短且易于使用,在具备专业技术的中心可作为胆道减压的首选方法。
研究设计与样本
- 系统评价与Meta分析,检索2005年1月至2023年12月电子数据库比较EUS-BD与ERCP治疗恶性远端胆道梗阻的RCT。
- 最终纳入5项RCT共519例患者,采用随机效应模型计算汇总比例、风险比(RR)和比值比。
主要发现
- EUS-BD相比ERCP总体技术成功的汇总RR为1.05(95%CI=0.96-1.16,P=0.246,I2=61%)。
- EUS-BD相比ERCP临床成功的汇总RR为0.99(95%CI=0.95-1.04,P=0.850,I2=0%)。
- ERCP组操作相关胰腺炎汇总发生率为7.20%(95%CI=3.60-13.80,I2=34%),EUS-BD组为零。
- EUS-BD相比ERCP支架功能障碍的汇总RR为0.48(95%CI=0.28-0.83,P=0.008,I2=7%)。
- EUS-BD加权平均操作时间为13.43(SD=10.12)分钟,ERCP为21.06(SD=6.64)分钟;EUS-BD平均支架通畅时间194.11(SD=52.12)天,ERCP为187(SD=60.70)天。
临床怎么用
- 在具备EUS-BD专业技术的中心,可考虑将EUS-BD作为恶性远端胆道梗阻胆道减压的首选方法。
- EUS-BD几乎无操作相关胰腺炎风险且支架功能障碍风险更低,适用于需避免ERCP术后胰腺炎的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Endoscopic ultrasound-guided biliary drainage (EUS-BD) is an alternative to endoscopic retrograde cholangiopancreatography (ERCP)-guided transpapillary drainage in malignant distal biliary obstruction (MDBO). This meta-analysis of randomized controlled trials (RCTs) aims to compare the outcomes of these 2 approaches. METHODS: Electronic databases from January 2005 through December 2023 were searched for RCTs comparing outcomes of EUS-BD and ERCP for treating MDBO. Pooled proportions, risk ratio (RR), and odds ratio were calculated using random-effects models. RESULTS: Five RCTs comprising 519 patients were included in the final analysis. The pooled RR for overall technical success with EUS-BD compared with ERCP was 1.05 (95% confidence interval [CI] = 0.96-1.16, P = 0.246, I2 = 61%) and for clinical success was 0.99 (95% CI = 0.95-1.04, P = 0.850, I2 = 0%). The pooled rate of procedure-related pancreatitis was 7.20% (95% CI = 3.60-13.80, I2 = 34%) in the ERCP group compared with zero in the EUS-BD group. The pooled RR for stent dysfunction with EUS-BD compared with ERCP was 0.48 (95% CI = 0.28-0.83, P = 0.008, I2 = 7%). The weighted mean procedure time was 13.43 (SD = 10.12) minutes for EUS-BD compared with 21.06 (SD = 6.64) minutes for ERCP. The mean stent patency was 194.11 (SD = 52.12) days in the EUS-BD group and 187 (SD = 60.70) days in the ERCP group. DISCUSSION: EUS-BD is an efficient and safe alternative to ERCP in MDBO. An almost nonexistent risk of procedure-related pancreatitis, lower procedure time, and ease of use make this an attractive primary approach to biliary decompression in centers with expertise.
引用
- Gopakumar H, Singh RR, Revanur V, et al. Endoscopic Ultrasound-Guided vs Endoscopic Retrograde Cholangiopancreatography-Guided Biliary Drainage as Primary Approach to Malignant Distal Biliary Obstruction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Gastroenterol. 2024. PMID: 38421018. doi:10.14309/ajg.0000000000002736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。